Businessweek

Hangzhou Tigermed Consulting Co., Ltd. operates as a contract research organization in China and internationally. It offers clinical trials services, including biometrics services across various phases of clinical trials in the areas of oncology, endocrinology, CNS, virology, and cardiology. The company provides clinical trial services, such as clinical trial planning, management, and implementation; essential documents preparation; study start-up; site clinical study agreement; monitoring; project management; safety report; QA and QC; and clinical study report writing. It also offers data management services, including CRF design, data management plan development, study database setup and validation, double data entry, computerized edit check, medical coding, discrepancy generation and resolution, blind review and database lock, and neCRF design and EDC system management. In addition, the company provides services in the area of biostatistics, such as statistical considerations and sample size calculation in protocol development; randomization list generation; statistical analysis plan development; SAS programming of statistical tables, listings, and figures; interim analysis; statistical analysis report writing; and final report review by statistician, as well as services in the area of regulatory affairs, including regulatory feasibility study, documents sorting and submission, sample testing arrangement, and IND and NDA tracking. Further, it offers medical translation services comprising handling inter-translations of Chinese, English, Japanese, Korean, and Spanish, as well as provision of written translation and simultaneous translation; and GCP training services for sponsors, research institutions, and clinical research professionals. Hangzhou Tigermed Consulting Co., Ltd. serves pharmaceutical, biopharmaceutical, and medical device companies. The company was founded in 2004 and is headquartered in Hangzhou, the People’s Republic of China.